Filing Details
- Accession Number:
- 0001181431-13-054156
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-10-17 11:21:33
- Reporting Period:
- 2013-10-15
- Filing Date:
- 2013-10-17
- Accepted Time:
- 2013-10-17 11:21:33
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
722104 | Savient Pharmaceuticals Inc | SVNT | Medicinal Chemicals & Botanical Products (2833) | 133033811 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1456864 | David Gionco | Savient Pharmaceuticals, Inc. 400 Crossing Blvd, 3Rd Floor Bridgewater NJ 08807 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-10-15 | 5,476 | $0.08 | 78,164 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-10-15 | 8,500 | $0.08 | 69,664 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-10-15 | 3,000 | $0.08 | 66,664 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-10-15 | 20,900 | $0.08 | 45,764 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-10-15 | 10,000 | $0.08 | 35,764 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |